Common Mistakes
    Storage

    I Forgot to Refrigerate My Semaglutide: Is It Still Good?

    A complete guide to GLP-1 medication storage, room temperature stability, and when you need to discard your medication.

    Last updated: March 15, 2026·14 min read

    Quick Answer

    If your semaglutide was left out overnight at normal room temperature (below 86°F/30°C), it is almost certainly still safe to use. Brand-name pens are stable at room temperature for up to 56 days. Compounded vials vary but typically last 28-30 days unrefrigerated. Check the visual appearance and return it to the fridge.

    You woke up and realized your semaglutide pen has been sitting on the bathroom counter all night. Or maybe it was in your bag for the entire day while you were at work. Before you panic and throw it away, here is the good news: semaglutide is more temperature-stable than most people think.

    Brand-Name Semaglutide Storage Rules

    The manufacturers of Ozempic and Wegovy have conducted extensive stability testing. Here is what their official prescribing information says:

    Official Storage Guidelines

    ConditionOzempicWegovyCompounded
    Refrigerated (36-46°F)Until expirationUntil expirationPer BUD date
    Room temp (up to 86°F)56 days56 days28-30 days*
    Above 86°FDiscardDiscardDiscard
    Below 32°F (frozen)DiscardDiscardDiscard

    *Compounded semaglutide BUD (beyond-use date) varies by pharmacy. Always check the label on your specific vial.

    Common Scenarios: Is Your Semaglutide Still Good?

    Left Out Overnight (8-12 Hours)

    Verdict: Almost certainly fine. If your home temperature stayed below 86°F (30°C), a single night at room temperature is well within the approved stability window. Return it to the refrigerator and use normally.

    Left Out All Day (12-24 Hours)

    Verdict: Still fine in most cases. The same 56-day room temperature stability applies. One day is a tiny fraction of the approved unrefrigerated window. Check the visual appearance: it should be clear and colorless.

    Left in a Car During Summer

    Verdict: Potentially compromised. Car interiors can exceed 120°F (49°C) on hot days, far above the 86°F maximum. If the car was in direct sunlight and temperatures likely exceeded 86°F for any significant period, discard the medication. If the car was in a garage or the weather was mild, it may still be fine.

    Left Out for Several Days

    Verdict: Usually fine, but start counting. Begin tracking how many days total the medication has been at room temperature. As long as the cumulative time below 86°F stays under 56 days (brand) or your pharmacy's specified BUD (compounded), it remains usable.

    Left in Checked Luggage on a Flight

    Verdict: Potentially problematic. Cargo holds on commercial aircraft can reach very low temperatures, potentially freezing your medication. They can also get warm during ground operations. If you suspect freezing occurred, read our guide on frozen semaglutide.

    How to Inspect Your Semaglutide

    After any temperature excursion, perform a visual inspection before using the medication. Semaglutide should always appear:

    Visual Inspection Checklist

    • Clear: The solution should be transparent, not hazy or cloudy
    • Colorless: No yellow, brown, or other discoloration
    • Particle-free: No floating particles, crystals, or sediment
    • No unusual odor: Semaglutide should be odorless
    • Intact packaging: No cracks in the pen or vial, seal not compromised

    If your medication fails any of these checks, do not use it. Cloudy or discolored semaglutide may indicate protein degradation, which can reduce effectiveness and potentially cause injection site reactions.

    Why Temperature Matters for Peptide Medications

    Semaglutide is a peptide, which means it is a chain of amino acids folded into a specific three-dimensional shape. This shape is what allows it to bind to GLP-1 receptors in your body and produce its therapeutic effects. Temperature extremes can cause the peptide to unfold or aggregate, a process called denaturation.

    What Heat Does

    Temperatures above 86°F (30°C) accelerate peptide degradation. The higher the temperature and the longer the exposure, the more the active ingredient breaks down. This does not create a toxic product; rather, it reduces the amount of active semaglutide in the solution. You would effectively be injecting a lower dose than intended, which could stall your weight loss progress.

    What Freezing Does

    Freezing causes ice crystals to form within the solution. These crystals can physically shear the peptide molecules and damage the three-dimensional structure. Freezing can also cause changes to the preservatives and buffers in the solution, affecting stability after thawing. This is why frozen semaglutide should always be discarded.

    Compounded Semaglutide: Different Rules

    If you are using compounded semaglutide from a compounding pharmacy, storage rules may differ from brand-name products. This is because compounded formulations:

    • May use different concentrations of semaglutide
    • Often contain different preservatives (like benzyl alcohol or bacteriostatic water)
    • Have beyond-use dates (BUD) determined by the specific pharmacy's stability testing
    • May not have the same extensive stability data as brand-name products

    Always check the label on your compounded vial for specific storage instructions and the beyond-use date. When in doubt, call your compounding pharmacy directly. They can tell you exactly how long your specific formulation is stable at room temperature.

    Tirzepatide Storage: Key Differences

    Tirzepatide (Mounjaro and Zepbound) has slightly different storage parameters:

    • Refrigerated: 36-46°F (2-8°C) until expiration date
    • Room temperature: Up to 86°F (30°C) for a maximum of 21 days (shorter than semaglutide's 56 days)
    • Once removed: Eli Lilly's guidance states that once tirzepatide is stored at room temperature, it should not be returned to the refrigerator
    • Compounded tirzepatide: Follow pharmacy-specific BUD dates

    Important Difference

    Tirzepatide has a shorter room temperature window (21 days) compared to semaglutide (56 days). If you use tirzepatide, be more careful about leaving it unrefrigerated for extended periods.

    Travel and Storage Best Practices

    Proper storage is especially challenging when traveling. Here are proven strategies from experienced GLP-1 users:

    For Short Trips (1-3 Days)

    • Your medication is fine at room temperature for the duration
    • Keep it out of direct sunlight and away from heat sources
    • A small insulated bag without ice packs is usually sufficient

    For Longer Trips

    • Use a medication-specific travel cooler (Frio, MedAngel, or similar)
    • Never put medication directly on ice or ice packs (risk of freezing)
    • Always carry medication in your carry-on, never in checked luggage
    • Request a mini-fridge at your hotel
    • A MedAngel Bluetooth thermometer can monitor temperature in your bag and alert you if it goes out of range

    At Home

    • Store in the main body of the refrigerator, not the door (more temperature fluctuation) and not near the back wall (risk of freezing)
    • A dedicated medication shelf or bin prevents items from being pushed to the back
    • Keep the backup supply refrigerated and only remove the pen you are currently using

    Getting a Replacement If You Need to Discard

    If you determine your medication has been compromised, here is how to get a replacement:

    • Contact your pharmacy: Explain the situation. Some pharmacies and insurance plans allow early refills for documented storage issues.
    • Contact your prescriber: They can send a new prescription or help with insurance overrides.
    • Manufacturer programs: Both Novo Nordisk and Eli Lilly have replacement programs for certain documented issues.
    • Insurance appeal: If your insurer denies an early refill, your provider can submit a coverage exception request.

    Key Takeaways

    • Brand-name semaglutide pens are stable at room temperature (below 86°F) for up to 56 days
    • One night or one day unrefrigerated is completely fine
    • Compounded semaglutide has shorter room-temperature windows; check your vial label
    • Tirzepatide is only stable at room temperature for 21 days
    • Always visually inspect: clear, colorless, particle-free
    • Never use medication that has been frozen or exposed to temperatures above 86°F
    • When in doubt, call your pharmacy or prescriber before discarding

    Medical Disclaimer: This article is for educational purposes only and is not a substitute for professional medical advice. Storage guidelines may vary by formulation and manufacturer. Always follow the specific storage instructions provided with your medication and consult your pharmacist or healthcare provider with questions about medication safety.

    Start Your GLP-1 Journey with Expert Support

    Our team provides clear storage and administration guidance with every prescription.

    Get Started Today

    Sources & References

    1. Wilding JPH et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. NEJM 2021;384:989-1002.
    2. Jastreboff AM et al. Tirzepatide Once Weekly for the Treatment of Obesity. NEJM 2022;387:205-216.
    3. Lincoff AM et al. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes. NEJM 2023;389:2221-2232.
    4. FDA Prescribing Information for Wegovy (semaglutide) and Zepbound (tirzepatide).

    What does the published clinical evidence show for compounded semaglutide?

    Peer-reviewed evidence: Adults with overweight or obesity on semaglutide 2.4 mg achieved a mean body weight reduction of approximately 14.9% at 68 weeks, compared with 2.4% on placebo. (Source: STEP 1, NEJM 2021). Trimi offers compounded semaglutide starting at $99/month on the annual plan, dispensed by 503A community sterile compounding pharmacies (VialsRx — Texas pharmacy license #35264 — and GreenwichRx). Results vary by individual; eligibility is determined by a licensed clinician.

    Adults with overweight or obesity on semaglutide 2.4 mg achieved a mean body weight reduction of approximately 14.9% at 68 weeks, compared with 2.4% on placebo. — STEP 1, NEJM 2021
    Approximately 86% of patients on continued semaglutide treatment maintained ≥5% body-weight reduction from baseline through 68 weeks, vs 33% in the placebo-switch arm. — STEP 4, JAMA 2021
    Semaglutide 2.4 mg reduced major adverse cardiovascular events (MACE) by 20% over a mean 39.8-month follow-up in adults with overweight/obesity and pre-existing cardiovascular disease without diabetes. — SELECT, NEJM 2023

    Key Takeaways

    • Adults with overweight or obesity on semaglutide 2.4 mg achieved a mean body weight reduction of approximately 14.9% at 68 weeks, compared with 2.4% on placebo. (Source: STEP 1, NEJM 2021)
    • Approximately 86% of patients on continued semaglutide treatment maintained ≥5% body-weight reduction from baseline through 68 weeks, vs 33% in the placebo-switch arm. (Source: STEP 4, JAMA 2021)
    • Semaglutide 2.4 mg reduced major adverse cardiovascular events (MACE) by 20% over a mean 39.8-month follow-up in adults with overweight/obesity and pre-existing cardiovascular disease without diabetes. (Source: SELECT, NEJM 2023)
    • Semaglutide is the active pharmaceutical ingredient; it is FDA-approved in the corresponding brand finished products (Wegovy and Ozempic). Trimi's compounded preparation of the same active ingredient is prepared per individual prescription by 503A community sterile compounding pharmacies and is not itself FDA-approved as a drug.
    • Eligibility requires evaluation by a licensed clinician: BMI ≥30, or BMI ≥27 with at least one weight-related comorbidity (type 2 diabetes, hypertension, dyslipidemia, obstructive sleep apnea, cardiovascular disease). Contraindications include personal or family history of medullary thyroid carcinoma, MEN 2 syndrome, pancreatitis, severe gastrointestinal disease, severe renal impairment, pregnancy, and breastfeeding.
    • Common GLP-1 receptor agonist adverse effects include nausea, vomiting, diarrhea, constipation, and gallbladder events. Dose titration over weeks improves tolerability. Severe gastrointestinal symptoms may cause dehydration and increase acute kidney injury risk.
    • This is general information based on the cited evidence, not medical advice. Treatment decisions require evaluation by a licensed clinician familiar with your individual medical history, BMI, and comorbidities.

    Medically Reviewed

    TMRT

    Trimi Medical Review Team

    Clinical review workflow for GLP-1 safety, dosing, and access content

    Team-based medical review process documented in Trimi's Medical Review Policy

    Last reviewed: March 26, 2026

    TCCT

    Written by Trimi Clinical Content Team

    Medical Writers & Healthcare Professionals

    Our clinical content team includes registered nurses, pharmacists, and medical writers who specialize in translating complex medical information into clear, actionable guidance for patients.

    Medically reviewed by Trimi Medical Review Team, Clinical review workflow for GLP-1 safety, dosing, and access content

    What real Trimi patients say

    Verbatim quotes from Trimi's Facebook and Reddit community reviews. First name and last initial preserved per editorial policy.

    Amazing company and care team support! Fast response time, no hidden fees and they actually care enough to work with you and your needs on your weight loss journey. Down 12.5 pounds in 2 months!

    Outcome: Down 12.5 lbs in 2 months

    Sarah MillerFacebook
    Arrived within 24 hours. Easy to use. Comes with everything. The year is so worth it.

    Outcome: Same-day delivery experience

    Veronica LarimoreFacebook

    Editorial Standards

    Trimi publishes patient education using a medical-review workflow, source-based claim checks, and dated updates for fast-changing pricing, access, and safety topics.

    Review our Editorial Policy and Medical Review Policy for more details about sourcing, updates, and reviewer attribution.

    Scientific References

    1. Wilding JPH, Batterham RL, Calanna S, et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1). New England Journal of Medicine.Read StudyDOI: 10.1056/NEJMoa2032183
    2. Rubino D, Abrahamsson N, Davies M, et al. (2021). Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity: The STEP 4 Randomized Clinical Trial. JAMA.Read StudyDOI: 10.1001/jama.2021.3224
    3. Garvey WT, Batterham RL, Bhatta M, et al. (2022). Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial. Nature Medicine.Read StudyDOI: 10.1038/s41591-022-02026-4
    4. Lincoff AM, Brown-Frandsen K, Colhoun HM, et al. (2023). Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes (SELECT). New England Journal of Medicine.Read StudyDOI: 10.1056/NEJMoa2307563
    5. Marso SP, Bain SC, Consoli A, et al. (2016). Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes (SUSTAIN-6). New England Journal of Medicine.Read StudyDOI: 10.1056/NEJMoa1607141
    6. Perkovic V, Tuttle KR, Rossing P, et al. (2024). Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes (FLOW). New England Journal of Medicine.Read StudyDOI: 10.1056/NEJMoa2403347

    Was this article helpful?

    Keep Reading

    Complete guide to semaglutide 1.7mg dosing. Learn about expected weight loss results, side effects at this higher dose, and how to decide between staying at 1.7mg or advancing to 2.4mg.

    Complete guide to combining semaglutide and metformin. Learn about safety, synergistic benefits for diabetes and weight loss, GI side effect management, and dose adjustment considerations.

    Guide to semaglutide 0.5mg dose increase. Learn what to expect at the first titration step, typical side effects, weight loss results, and when to advance to 1.0mg.

    Complete guide to semaglutide 0.25mg starting dose. Learn what to expect during your first 4 weeks, common side effects, expected weight loss, and when to increase your dose.

    Start your GLP-1 journey — from $99/mo

    Get Started